当前位置: X-MOL 学术Diabetes Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries.
Diabetes Care ( IF 16.2 ) Pub Date : 2019-10-31 , DOI: 10.2337/dc19-1214
Kellee M Miller 1 , Julia Hermann 2, 3 , Nicole Foster 4 , Sabine E Hofer 5 , Michael R Rickels 6 , Thomas Danne 7 , Mark A Clements 8 , Eggert Lilienthal 9 , David M Maahs 10, 11 , Reinhard W Holl ,
Affiliation  

Continuous glucose monitoring (CGM) has been demonstrated in randomized trials to improve glucose control in patients with type 1 diabetes (1), but until recently only a minority of participants in the German/Austrian Diabetes Patienten Verlaufsdokumentation (DPV) registry and the U.S.-based T1D Exchange (T1DX) registry were using CGM (2,3). Over the past decade, both the accuracy and usability of CGM devices have improved considerably with expanded cost coverage of CGM by government statutory and private insurance. Some CGM devices are regulatory body approved for determining insulin dose in most circumstances, thereby reducing the number of fingersticks needed to monitor blood glucose. To assess change in CGM use over time across the age spectrum, we analyzed data from the T1DX and DPV registries for the years 2011, 2013, 2015, and 2017. CGM use (including both real-time and intermittent scanning CGM) at each data collection time point were obtained from clinic medical records. The number of participants with available data on CGM usage varied slightly depending on the calendar year for both registries. In DPV, the cohort size ranged from 17,632 to 21,707 for youth (aged 2 to <18 years) and from 7,651 to 8,390 for adults aged (≥18 years). In T1DX, cohort size ranged from 8,334 to 9,184 …

中文翻译:

1型糖尿病患者连续血糖监测使用的纵向变化:德国和奥地利DPV和美国T1D交易注册中心的国际比较。

在随机试验中已经证明了连续血糖监测(CGM)可以改善1型糖尿病患者的血糖控制(1),但是直到最近,德国/奥地利糖尿病患者Verlaufsdokumentation(DPV)登记册和美国-基于T1D交换(T1DX)的注册表均使用CGM(2,3)。在过去的十年中,随着政府法定保险和私人保险扩大了CGM的成本覆盖范围,CGM设备的准确性和可用性都得到了极大的提高。在大多数情况下,某些CGM设备已获监管机构批准,可用于确定胰岛素剂量,从而减少了监测血糖所需的指尖数量。为了评估跨年龄段的CGM使用随时间的变化,我们分析了T1DX和DPV注册管理机构2011、2013、2015和2017年的数据。从临床医疗记录中获取每个数据收集时间点的CGM使用(包括实时和间歇扫描CGM)。可获得有关CGM使用数据的参与者的数量略有不同,这取决于两个注册管理机构的日历年。在DPV中,年轻人(2岁至<18岁)的队列规模从17,632到21,707,年龄在18岁以上(18岁以上)的成年人的队列规模从7,651到8,390。在T1DX中,同类群组的规模从8,334到9,184… 年龄(≥18岁)的成年人为390。在T1DX中,同类群组的规模从8,334到9,184… 年龄(≥18岁)的成年人为390。在T1DX中,同类群组的规模从8,334到9,184 ...
更新日期:2019-12-21
down
wechat
bug